Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Upper limb (UL) impairment is a common deficit following stroke with only an estimated 20 per cent of patients recovering function.
Upper limb (UL) impairment is a common deficit following stroke with only an estimated 20 per cent of patients recovering function. Pain associated with UL impairment due to multifactorial causes is a frequent symptom in patients with stroke. Occupational therapy techniques focus on the implementation of positioning techniques and the use of supportive devices (SD) such as slings aimed to prevent pain; therefore increase daily function, participation and hence quality of life. At present, positioning principles of the hemiplegic shoulder exist in clinical practice. These are aimed at prevention of pain associated with UL Impairment; however there is no clear consensus among professionals of particular SD that should be implemented for adults with stroke
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| the EO31 shoulder sling | Experimental | To develop and evaluate the effects of the EO31 shoulder sling for the prevention of pain, subluxation, spasticity, as well as effect on increasing functional use of the UL in activities of daily living. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Evaluate the effects of the EO31 shoulder sling in adults post-stoke | Device | Investigator want to evaluate the efficient of the EO31 shoulder sling in adults post-stroke. The EO31 shoulder sling is made-to-measure shoulder pads for upper limb after cerebrovascular accident |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluate the effects of the EO31 shoulder with Goal Attainment Scale (GAS) scale | GAS (Goal Attainment Scale) scores will be described with regards to the 3 client-centred objectives. The score for each objective is comprised between -2 (when objective is not achieve) to 2 (achieve objective). | 5 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluate shoulder pain with Visual Analog Scale for Pain (EVA scale) | The shoulder pain will be evaluate with th sling with EVA Scale. Eva scale is between 0 (no pain) to 10 (big pain) | 24 hours |
| Evaluate shoulder pain with EVA scale |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Evelyne Castel-Lacanal, MD | University Hospital, Toulouse | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de Toulouse | Toulouse | 31000 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40845630 | Result | Montane E, Pradie M, Bigarre I, Lebely C, Lelievre A, Cormier C, Butterworth J, Lepage B, Marque P, de Boissezon X, Castel-Lacanal E. A custom-made sling to achieve personal goals in shoulder pain or subluxation in the subacute stroke phase: a pilot study. Ann Phys Rehabil Med. 2025 Oct;68(7):102014. doi: 10.1016/j.rehab.2025.102014. Epub 2025 Aug 21. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The shoulder pain will be evaluate with th sling with EVA Scale. Eva scale is between 0 (no pain) to 10 (big pain).
| 5 weeks |
| Evaluate shoulder pain with EVA scale | The shoulder pain will be evaluate with th sling with EVA Scale. Eva scale is between 0 (no pain) to 10 (big pain). | baseline |
| Spasticity with TARDIEU scale | Evaluate the spasticity of upper limb with TARDIEU scale: the rotation angle of the shoulder, elbow and wrist are measured | baseline |
| Spasticity with TARDIEU scale | Evaluate the spasticity of upper limb with TARDIEU scale: the rotation angle of the shoulder, elbow and wrist are measured | 7 days |
| Spasticity with TARDIEU scale | Evaluate the spasticity of upper limb with TARDIEU scale: the rotation angle of the shoulder, elbow and wrist are measured | 14 days |
| Spasticity with TARDIEU scale | Evaluate the spasticity of upper limb with TARDIEU scale: the rotation angle of the shoulder, elbow and wrist are measured | 5 weeks |
| Number of daily use of the upper limb sling | Evaluate if patient use the sling : number of use by day | 5 weeks |
| Clinical measure of appendage | Evaluate of appendage with clinical measure during all the treatment. This measure is in millimeter | baseline |
| Clinical measure of appendage | Evaluate of appendage with clinical measure during all the treatment. This measure is in millimeter | 7 days |
| Clinical measure of appendage | Evaluate of appendage with clinical measure during all the treatment. This measure is in millimeter | 14 days |
| Clinical measure of appendage | Evaluate of appendage with clinical measure during all the treatment. This measure is in millimeter. | 5 weeks |
| motor function of upper limb with Chedoke Arm and Hand Activity Inventory (CAHAI) scale | the motor function of the upper limb will be evaluate with CAHAI scale between 13 (motor function low) to 94 (motor function strong) | baseline |
| motor function of upper limb with CAHAI scale | the motor function of the upper limb will be evaluate with CAHAI scale between 13 (motor function low) to 94 (motor function strong) | 7 days |
| motor function of upper limb with CAHAI scale | the motor function of the upper limb will be evaluate with CAHAI scale between 13 (motor function low) to 94 (motor function strong) | 5 weeks |
| questionnaire for quality of patient's life | the quality of patient's life will be evaluate with ESAT scale between 0 (quality of life low) and 60 (good quality of life) | baseline |
| questionnaire for quality of patient's life | the quality of patient's life will be evaluate with ESAT scale between 0 (quality of life low) and 60 (good quality of life) | 5 weeks |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |